U.S. President Donald Trump signed an executive order aimed at expanding access to in vitro fertilization (IVF) and reducing treatment costs. The order directs the administration to develop policy recommendations within 90 days to protect IVF access and lower expenses. However, it does not specify funding sources.
Currently, most states do not mandate insurance coverage for IVF, which involves fertilizing eggs and sperm in a lab. Even with insurance, costs can range from $12,000 to $25,000 per cycle, often requiring multiple attempts. The White House stated that over 85,000 babies were born through IVF in 2021, citing data from the Department of Health and Human Services.
Trump’s order seeks to remove unnecessary legal and regulatory hurdles that drive up costs, reinforcing his campaign promise to ensure government or insurance-backed IVF funding. The U.S. fertility rate has been declining, dropping 3% in 2023 and averaging a 2% annual decrease between 2014 and 2020. In 2022, the birth rate was 1.67 births per woman, below the 2.1 replacement rate necessary for population stability without immigration.
IVF became a key election issue following a controversial Alabama Supreme Court ruling that classified embryos as children, raising concerns about embryo storage and transportation. The decision led some patients to consider moving their embryos out of the state. Senate Republicans blocked Democratic-led IVF protection legislation twice in 2024, arguing that access was not at risk.
Trump’s executive order mandates a review of policies contributing to high IVF costs, including those requiring legislative changes. His initiative underscores the growing political focus on reproductive healthcare and its impact on families struggling with infertility.


Senate Majority Leader John Thune Moves to Advance Crypto Clarity Act
U.S. Unseals Charges Against Five Alleged CJNG Leaders, Raises Reward for New Cartel Chief
Trump Administration Weighs Executive Order on Vaccines and Autism Research
Eli Lilly Eyes AtaiBeckley Acquisition to Expand Psychedelic Mental Health Pipeline
UNAIDS Urges U.S. to Reconsider South Africa HIV Funding Withdrawal
GSK Unveils $2.52 Billion Cost-Cutting Plan to Accelerate Drug Pipeline
Global Leaders Push Back as Trump Imposes New Forced Labor Tariffs
US Expects Iran-Oman Hormuz Shipping Deal Soon
The government is ‘doubling down’ on its social media ban. But bigger penalties for platforms aren’t enough
AstraZeneca, Bristol Myers Squibb Explore Mega Merger Worth Nearly $400 Billion
US Expands Social Media Vetting to Foreign Journalists Seeking Visas
Russia Intensifies Drone and Bomb Attacks on Ukraine’s Zaporizhzhia, Deepening Civilian Fear
US-Backed Venezuela Government, Opposition Talks Begin
SEC Moves to Dismiss Insider Trading Case Against Trump-Pardoned Terren Peizer
Germany Warns of Daily Hybrid Warfare Threats
Abdul El-Sayed Wins Michigan Democratic Senate Primary, Sets Up Key Midterm Showdown 



